Prostarmon E en es it fr

Prostarmon E Brand names, Prostarmon E Analogs

Prostarmon E Brand Names Mixture

  • No information avaliable

Prostarmon E Chemical_Formula


Prostarmon E RX_link

Prostarmon E fda sheet

Prostarmon E msds (material safety sheet)

Prostarmon_E MSDS

Prostarmon E Synthesis Reference

No information avaliable

Prostarmon E Molecular Weight

352.465 g/mol

Prostarmon E Melting Point

67 oC

Prostarmon E H2O Solubility

58.1 mg/L

Prostarmon E State


Prostarmon E LogP


Prostarmon E Dosage Forms

Gel; Insert (suppository containing 20 mg of dinoprostone); Tablet

Prostarmon E Indication

For the termination of pregnancy from the 12th through the 20th gestational week as calculated from the first day of the last normal menstrual period. Also for evacuation of the uterine contents in the management of missed abortion or intrauterine fetal death up to 28 weeks of gestational age as calculated from the first day of the last normal menstrual period, and also used in the management of nonmetastatic gestational trophoblastic disease (benign hydatidiform mole).

Prostarmon E Pharmacology

Dinoprostone is equivalent to prostaglandin E2 (PGE2). It stimulates labor and delivery and thus terminates pregnancy. Dinoprostone is also capable of stimulating the smooth muscle of the gastrointestinal tract of man. This activity may be responsible for the vomiting and/or diarrhea that is not uncommon when dinoprostone is used to terminate pregnancy.

Prostarmon E Absorption

Absorbed at a rate of 0.3 mg per hour over 12 hours while the vaginal system is in place.

Prostarmon E side effects and Toxicity

Oral, mouse: LD50 = 750 mg/kg; Oral, rat: LD50 = 500 mg/kg.

Prostarmon E Patient Information

No information avaliable

Prostarmon E Organisms Affected

Humans and other mammals